Literature DB >> 8379382

Signals required for differentiating dendritic cells from human monocytes in vitro.

J H Peters1, H Xu, J Ruppert, D Ostermeier, D Friedrichs, R K Gieseler.   

Abstract

Human peripheral blood monocytes (Mo) can quantitatively be differentiated into potent accessory cells which exhibit dendritic cell (DC) function and phenotype. This alternative differentiation of Mo into DC rather than into macrophages (M phi) will be triggered when signals leading to M phi differentiation are omitted from the culture. Serum contains such stimulatory signals and was therefore omitted from the cultures. The cells were cultured on solid agarose surfaces. This newly developed technique allows for the attachment-free differentiation of DC. In the absence of signals, Mo do not survive in culture. IL-1 and IL-6 are endogenously produced by Mo and create an autokrine stimulatory milieu which increases the accessory function. However, also mature Mph will respond by an increased accessory activity upon stimulation by these cytokines. Cyclic AMP is the most likely second messenger to trigger an increase in accessory activity. IL-4 plus GM-CSF further act to upregulate dendritic cell properties and function. By action of these mediators, virtually all markers and functions of Mo/M phi are lost, and the cells convert to the phenotype and function of dendritic cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379382     DOI: 10.1007/978-1-4615-2930-9_46

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Human dendritic cell subsets for vaccination.

Authors:  Peter Dubsky; Hideki Ueno; Bernard Piqueras; John Connolly; Jacques Banchereau; A Karolina Palucka
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

Review 2.  Neutrophils at work.

Authors:  William M Nauseef; Niels Borregaard
Journal:  Nat Immunol       Date:  2014-07       Impact factor: 25.606

Review 3.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Foxp3-independent mechanism by which TGF-β controls peripheral T cell tolerance.

Authors:  Soyoung A Oh; Ming Liu; Briana G Nixon; Davina Kang; Ahmed Toure; Michael Bivona; Ming O Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

5.  HIV-1 infection of placental cord blood monocyte-derived dendritic cells.

Authors:  R M Folcik; J D Merrill; Y Li; C J Guo; S D Douglas; S E Starr; W Z Ho
Journal:  J Hematother Stem Cell Res       Date:  2001-10

Review 6.  RNA vaccines in cancer treatment.

Authors:  Anita Bringmann; Stefanie Andrea Erika Held; Annkristin Heine; Peter Brossart
Journal:  J Biomed Biotechnol       Date:  2010-06-01

7.  Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents.

Authors:  Nataša Obermajer; Julie Urban; Eva Wieckowski; Ravikumar Muthuswamy; Roshni Ravindranathan; David L Bartlett; Pawel Kalinski
Journal:  Nat Protoc       Date:  2018-01-18       Impact factor: 13.491

8.  Advances in cellular therapy for the treatment of thyroid cancer.

Authors:  Claudia Papewalis; Margret Ehlers; Matthias Schott
Journal:  J Oncol       Date:  2010-06-29       Impact factor: 4.375

9.  Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries?

Authors:  J Banchereau; B Pulendran; R Steinman; K Palucka
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

10.  HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.

Authors:  Thomas Musich; Olivia O'Connell; Maria Paz Gonzalez-Perez; Cynthia A Derdeyn; Paul J Peters; Paul R Clapham
Journal:  Retrovirology       Date:  2015-03-14       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.